Inhibitex, Inc. to Present at Two Upcoming Conferences

ATLANTA--(BUSINESS WIRE)--Inhibitex, Inc. (NASDAQ:INHX), a biopharmaceutical company focused on developing products to treat and prevent serious infectious diseases, announced that executive management is scheduled to present an overview of the company and its pipeline at the following two conferences:

Back to news